SCHEMBL6178544

SCHEMBL6178544

Cc1cccc(S(=O)(=O)N2CCCC2c2ccc(F)cc2)c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 7/20 0.70
HTR1A P08908 1/20 0.51
DRD2 P14416 1/20 0.51
HTR1D P28221 1/20 0.51
HTR1B P28222 1/20 0.51
HTR7 P34969 1/20 0.51
DRD3 P35462 1/20 0.51
LOXL2 Q9Y4K0 2/20 0.47
GLA P06280 1/20 0.47
NR3C2 P08235 1/20 0.46
PSEN1 P49768 1/20 0.45
PSEN2 P49810 1/20 0.45
APH1B Q8WW43 1/20 0.45
NCSTN Q92542 1/20 0.45
APH1A Q96BI3 1/20 0.45
PSENEN Q9NZ42 1/20 0.45
THRB P10828 1/20 0.44
LMNA P02545 2/20 0.44
MAPT P10636 2/20 0.44
PAX8 Q06710 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6178548 1.00 TRPA1 (0.70) TRPA1HTR1ADRD2HTR1DHTR1B
SCHEMBL6179787 0.90 TRPA1 (0.77) TRPA1LOXL2PSEN1PSEN2APH1B
SCHEMBL6179785 0.90 TRPA1 (0.77) TRPA1LOXL2PSEN1PSEN2APH1B
SCHEMBL6176643 0.88 TRPA1 (0.70) TRPA1HTR7GLAPSEN1PSEN2
SCHEMBL6176638 0.88 TRPA1 (0.70) TRPA1HTR7GLAPSEN1PSEN2
SCHEMBL3731913 0.85 TRPA1 (0.86) TRPA1HTR7GLANR3C2PSEN1
SCHEMBL6177805 0.85 TRPA1 (0.86) TRPA1HTR7GLANR3C2PSEN1
SCHEMBL3731910 0.85 TRPA1 (0.86) TRPA1HTR7GLANR3C2PSEN1
SCHEMBL6177808 0.85 TRPA1 (0.86) TRPA1HTR7GLANR3C2PSEN1
SCHEMBL6178197 0.85 TRPA1 (0.86) TRPA1HTR7GLANR3C2PSEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1165510-B1 1-ARENESULFONYL-2-ARYL-PYRROLIDINE AND PIPERIDINE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS HOFFMANN LA ROCHE (CH) 2005-09-28 EP disclosed
EP-1165510-A1 1-ARENESULFONYL-2-ARYL-PYRROLIDINE AND PIPERIDINE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2002-01-02 EP disclosed
US-6284785-B1 HAVING ACTIVITY AS LIGANDS OF METABOTROPIC GLUTAMATE RECEPTORS HOFFMANN- LA ROCHE INC. 2001-09-04 US disclosed
WO-2000058285-A1 1-ARENESULFONYL-2-ARYL-PYRROLIDINE AND PIPERIDINE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2000-10-05 WO disclosed